Status:
UNKNOWN
Oral Oxytocin's Effects on Attention Control
Lead Sponsor:
University of Electronic Science and Technology of China
Conditions:
Healthy
Eligibility:
MALE
18-30 years
Phase:
NA
Brief Summary
The main aim of the study is to investigate whether orally administered oxytocin (24IU) could modulate attention control using a social-emotional saccade/antisaccade eye-tracking paradigm.
Detailed Description
Numerous studies have reported the effect of intranasally administered oxytocin on attentional processing including stimulus-driven bottom-up processing and top-down goal-directed inhibitory control. ...
Eligibility Criteria
Inclusion
- Male, healthy participants
- Non smokers
Exclusion
- Previous or current medical, psychiatric, neurological disorder
- Regular medication
- Use of any psychoactive substances in the 24 hours before experiment
- Contra-indications for oxytocin
- Contra-indications for eye-tracking data acquisition
Key Trial Info
Start Date :
July 28 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04493515
Start Date
July 28 2020
End Date
December 31 2021
Last Update
July 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Electronic Science and Technology of China(UESTC)
Chengdu, Sichuan, China, 611731